Outcomes associated with allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma in the era of novel agents.
Cancer medicine（2023）
摘要
Despite the advent of novel therapies, allo-HCT remains an important therapeutic option for patients with R/R HL.
更多查看译文
关键词
Allo-HCT,Hodgkin lymphoma,allogeneic hematopoietic cell transplantation,relapsed/refractory,survival
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要